NCX-2012.9.30-6K Earnings Release




UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER
 
Pursuant to Rule 13a-16 or 15d-16

Under The Securities Exchange Act of 1934
 
For the month of November 2012

Commission File Number: 1-13064
 
NOVA Chemicals Corporation
 
1000 Seventh Avenue S.W., Calgary, Alberta, Canada, T2P 5L5
(Address of principal executive office)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x
Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
 
A copy of the Registrant’s:
(a)
Interim financial statements and interim Management’s Discussion & Analysis for the third quarter, three months ended September 30, 2012
(b)
Section 302 certification of principal executive officer; and
(c)
Section 302 certification of principal financial officer;
 
are furnished herewith.
 
Controls and Procedures
 
(a)
Evaluation of disclosure controls and procedures.  Based on our management’s evaluation (with the participation of our principal executive officer and principal financial officer), as of September 30, 2012, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the “Exchange Act”)) are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
(b)
Changes in internal controls.  There were no changes in our internal control over financial reporting that occurred during our fiscal quarter ended September 30, 2012 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
 
 




SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
NOVA Chemicals Corporation
 
 
 
 
 
/s/ Alan S. Pretter
 
Alan S. Pretter
 
Corporate Secretary
 
 
 
 
November 1, 2012
 

2


EXHIBITS
 
Attached hereto is:
 
99.1
 
Interim financial statements and interim Management’s Discussion & Analysis of NOVA Chemicals Corporation for the third quarter, three months ended September 30, 2012;
 
 
 
99.2
 
Section 302 certification of principal executive officer; and
 
 
 
99.3
 
Section 302 certification of principal financial officer.



3